Source Name : Investor's Business Daily (subscription) Source Url : http://www.investors.com Publish Date : Jan 28, 2009
Summary :Mylan (MYL), the drugmaker, has received the FDA's OK for its generic version of the epilepsy and bipolar disorder drug Lamictal. It climbed 1.2% to 11.65. ...
Shopping :
<< Go Back to Search Results
ADVERTISEMENT
Top Stories | World | US | Business | Sci-Tech | Sports | Entertainment | Health News Headlines are derived from different resources and none are affiliated with NewsZoom.com Copyright © 2003 - 2006 NewsZoom.com - an Adiant company. All Rights Reserved.